← Leaderboards
Christine Iok In Chio
Columbia University Health Sciences
$5,403,170
Attributed
$5,403,170
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,403,170 · 4
By mechanism
R01$4,981,139 · 3
R21$422,031 · 1
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Ravichandran Ramasamy$27,700,144
- Daniele Canzio$5,893,929
- William S Blaner$18,785,143
- Mohammad Athar$24,147,707
Others in their field
Other Emerging Leaders on “Pancreatic Tumorigenesis”
- Moran Amit · University Of Tx Md Anderson Can Ctr$4,827,924
- Florencia McAllister · University Of Tx Md Anderson Can Ctr$3,653,632
- Lydia Finley · Sloan-Kettering Inst Can Research$3,428,023
- Liam J Holt · New York University School Of Medicine$3,229,437
- Kian H Lim · Washington University$2,422,136
- Monther Abu-Remaileh · Stanford University$2,360,558
Research focus
Pancreatic TumorigenesisMalignant Neoplasm Of PancreasMetabolicOrganoidsPancreatic Ductal AdenocarcinomaMalignant NeoplasmsIn VivoProteinsPancreatic Ductal Adenocarcinoma CellEnzymesKras2 GeneResistanceTranslationsBiologyBiochemical ToolsProtein BiosynthesisMutationGenetically Engineered MouseIn VitroMouse ModelGrowthOxidation-ReductionPancreatic Cancer CellsNeoplastic Cell
Grant awards (14)
Characterizing the role of MSRA in pancreatic tumorigenesis$458,340
R01 · FY2025 · CA · contact PI
Studying the role of eIF4A in Pancreatic Cancer$446,188
R01 · FY2025 · CA · contact PI
Characterizing the role of MSRA in pancreatic tumorigenesis$435,911
R01 · FY2024 · CA · contact PI
Studying the role of eIF4A in Pancreatic Cancer$423,880
R01 · FY2024 · CA · contact PI
NRF2-dependent redox signaling in pancreatic cancer$347,716
R01 · FY2024 · CA · contact PI
Characterizing the role of MSRA in pancreatic tumorigenesis$466,179
R01 · FY2023 · CA · contact PI
Studying the role of eIF4A in Pancreatic Cancer$437,264
R01 · FY2023 · CA · contact PI
NRF2-dependent redox signaling in pancreatic cancer$358,826
R01 · FY2023 · CA · contact PI
Repurposing Bazedoxifene for chemoprevention in pre-invasive pancreatic cancer IPMN$183,489
R21 · FY2023 · CA · contact PI
Studying the role of eIF4A in Pancreatic Cancer$507,629
R01 · FY2022 · CA · contact PI
NRF2-dependent redox signaling in pancreatic cancer$366,278
R01 · FY2022 · CA · contact PI
Repurposing Bazedoxifene for chemoprevention in pre-invasive pancreatic cancer IPMN$238,542
R21 · FY2022 · CA · contact PI
NRF2-dependent redox signaling in pancreatic cancer$366,403
R01 · FY2021 · CA · contact PI
NRF2-dependent redox signaling in pancreatic cancer$366,525
R01 · FY2020 · CA · contact PI